Correction to: Signal Transduction and Targeted Therapy https://doi.org/10.1038/s41392-023-01718-8, published online 16 December 2023
In this article1 Mengyu Guo, Mingjing Cao, and Jiufeng Sun are equally contributing authors. This information is presented in the accepted version of the manuscript, but was inadvertently overlooked during the production process.
The original article has been corrected.
Reference
Guo, M. et al. Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine. Sig. Transduct. Target. Ther. 8, 462, https://doi.org/10.1038/s41392-023-01718-8 (2023).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Guo, M., Cao, M., Sun, J. et al. Correction: Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine. Sig Transduct Target Ther 9, 22 (2024). https://doi.org/10.1038/s41392-024-01739-x
Published:
DOI: https://doi.org/10.1038/s41392-024-01739-x
